Subscribe To
RNUGF / ReNeuron highlights exosome platform R&D progress
ReNeuron said it had taken an important step forward with plans to differentiate its exosome platform by generating in vivo data highlighting its distinct organ and cellular targeting capabilities. Iain Ross, executive chairman, said: "On the basis of this data the company will now look to broaden its capabilities and, in liaison with partners and collaborators, focus on the functional delivery of specific payloads”s.
Read More
Posted: Sep 4 2023, 03:43
Author Name: Proactive Investors
Views: 101920
RNUGF News
By Proactive Investors
September 4, 2023
ReNeuron highlights exosome platform R&D progress
ReNeuron said it had taken an important step forward with plans to differentiate its exosome platform by generating in vivo data highlighting its dist more_horizontal